Eli Lilly's third-quarter revenue and earnings
Statements (10)
- Bullish
Eli Lilly reported a net income of US$ 6.45 billion for the third quarter of 2026.
- Bullish
Eli Lilly's third-quarter net income increased 16% year over year.
- Bullish
Eli Lilly reported third-quarter revenue growth and raised its sales guidance.
- Bearish
Eli Lilly's projected operating income is expected to decrease slightly.
- Bullish
Eli Lilly reported a per-share adjusted net income of $7.48 for the third quarter of 2026
- Bullish
Eli Lilly reported a profit increase in its third quarter compared to the previous year.
- Bullish
Eli Lilly's revenue for the third quarter of fiscal 2026 climbed 39% compared to the same period a year ago to reach $24.4 billion
- Bullish
Lilly reported third-quarter 2026 revenue of $24.4 billion, a 39% increase from the prior period.
- Neutral
Eli Lilly is scheduled to report third-quarter earnings and revenue.
- Bearish
Eli Lilly's earnings per share estimate collapsed by a third in just 30 days